Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment? A case report

Claudio Cerchione, Davide Nappi, Gerardo Musuraca, Alessandro Lucchesi, Ilaria Cimmino, Fabrizio Pane, Amalia De Renzo, Giovanni Martinelli

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment? A case report'. Together they form a unique fingerprint.

Medicine & Life Sciences